Tasonermin

Therapeutic indications

Tasonermin is indicated for:

Soft tissue sarcoma of the limbs

Population group: only adults (18 years old or older)

Tasonermin is indicated in adults as an adjunct to surgery for subsequent removal of the tumour so as to prevent or delay amputation, or in the palliative situation, for irresectable soft tissue sarcoma of the limbs, used in combination with melphalan via mild hyperthermic isolated limb perfusion (ILP).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Tasonermin is contraindicated in the following cases:

Pregnancy

Pregnancy

Lactation

Lactation

Cardiovascular disease, pulmonary embolism

at least one of
Cardiovascular disorder
Pulmonary embolism

Severe pulmonary dysfunction

Lung disorder

Peptic ulcer

Peptic ulcer

Severe ascites

Ascites

Leucocytes <2.5 x 10⁹/l, haemoglobin <9 g/dl, platelets <60 x 10⁹/l, bleeding

at least one of
Decreased blood leukocyte number
† Haemoglobin very low
Platelet count below reference range
Bleeding

Significant renal dysfunction

at least one of


Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Significant hepatic dysfunction

Hepatic failure stage IV

Hypercalcaemia

Hypercalcemia

Anthracyclines

Anthracyclines and related substances

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.